Virtu Financial’s Mangoceuticals MGRX Stock Holding History

Virtu Financial’s Portfolio MGRX Stock Details MGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-61,028	Closed	-$22K	–	1984
2026 Q1	$22K	Buy	61,028 +27,566	+82%	+$13.2K	﹤0.01%	1387
2025 Q4	$25K	Buy	+33,462	New	+$54.3K	﹤0.01%	1390
2025 Q1	–	Sell	-20,501	Closed	-$50K	–	1764
2024 Q4	$50K	Buy	20,501 +19,245	+1,532%	+$50.4K	﹤0.01%	1162
2024 Q3	$4K	Sell	1,256 -5,324	-81%	-$25.1K	﹤0.01%	1255
2024 Q2	$30K	Buy	+6,580	New	+$30.5K	﹤0.01%	978
2023 Q4	–	Sell	-1,565	Closed	-$21K	–	1841
2023 Q3	$21K	Buy	+1,565	New	+$29.3K	﹤0.01%	1010

Other funds holding MGRX

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ACA

Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Virtu Financial's MGRX Position: Q2 2026 in Review

Virtu Financial sold out of Mangoceuticals (MGRX) in Q2 2026, closing a stake of 61,028 shares — an estimated $22K sold.

Virtu Financial first reported a position in MGRX in Q3 2023 and held it in 6 quarters. The position peaked at $50K in Q4 2024. 18 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

Virtu Financial reported no remaining Mangoceuticals position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 61,028 Mangoceuticals shares in Q2 2026, an estimated $22K.
Virtu Financial first reported a position in Mangoceuticals in Q3 2023 and held it in 6 quarters.
Virtu Financial's Mangoceuticals position peaked at $50K in Q4 2024.
18 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.